CANNABIS
Avtar Dhillon
Executive Chairman,
Emerald Health Therapeutics
Follow
About Avtar
Avtar Dhillon is a life sciences entrepreneur with more than 20 years' experience building public companies through mergers and acquisitions, leading innovation in scientific, engineering, and farming enterprises, securing government grants and NGO funding (more than $75 million US to date), and building dominant IP portfolios through partnering. During his tenure as president and CEO at Inovio (NASDAQ: INO), he led the turnaround of the company through restructuring and acquisitions.
Avtar's Videos
Since inception Emerald has focused on developing cannabis based medicines, backed by clinical efficacy, with standard dosing and conventional delivery mechanisms. This presentation will cover how Emerald plans to achieve this goal, in a differentiated take on the burgeoning cannabis industry.
Avtar Dhillon
CANNABIS
19:06
When looking at the potential catalysts for the Canadian cannabis industry, none is more significant than the legalization of recreational cannabis at the federal level. This development will serve as a catalyst to the entire cannabis industry and this panel of licensed medical cannabis producers will discuss how they are in position to capitalize on the burgeoning cannabis industry.
Avtar Dhillon
CANNABIS
45:23